StockData
Kura Oncology, Inc. logo

Kura Oncology, Inc. (KURA) stock

KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$7.34−0.15 (-2.00%)

Close on Nov 18, 2026Market cap $652.97MP/E –Yield –

Kura Oncology operating margin

Operating margin is operating income as a percentage of revenue.

Kura Oncology's operating margin for the twelve months ending Sep 30, 2026 was -394.3%. For fiscal 2025 it was -449.9%, against -358.5% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-449.9%−91.4
FY2024Dec 31, 2024-358.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-326.9%+58.6
Q2 FY2026Jun 30, 2026-349.8%+125.5
Q1 FY2026Mar 31, 2026-431.5%+27.1
Q4 FY2025Dec 31, 2025-497.6%–
Q3 FY2025Sep 30, 2025-385.5%–
Q2 FY2025Jun 30, 2025-475.3%–
Q1 FY2025Mar 31, 2025-458.6%–

More Kura Oncology figures

See a number that looks wrong?